Atlas Trials

Open Label Extension Assessing the Tolerability of BCI-024 in Combination With BCI-049 in Patients With Major Depressive Disorder (MDD)

Clinical trial NCT00731653 · COMPLETED

Trial details

NCT number
NCT00731653
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2008-07-01
Primary completion
2008-12-01
Enrollment
81

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.